House Democrats
Blue Dogs Seek to Delay Democratic Budget Plan After Their PAC Takes Millions From Corporate America
The House Blue Dog PAC has received donations from pharmaceutical giants, health care companies, and the fossil fuel industry this year as nearly half of their members seek to delay a vote on the Democrats’ budget plan.
Categories
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Categories
Koch Group Fights Drug Price Reforms After Taking Big Pharma Money
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.
Categories